Is Incyte Corporation overvalued?

Incyte Corporation (INCY) looks undervalued — trading about 25% below its fair value.

Undervalued

Price

$120.97

Fair value

$150.61

Current P/E

18.9

Normal P/E

23.5

Market cap

$24.66B

Dividend yield

0.0%

Return on equity

7.1%

Sector

Healthcare

Fair value compares INCY's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks